HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

It takes a team: a gain-of-function story of p53-R249S.

Abstract
Gain-of-function (GOF), the most malicious oncogenic activity of a cancer-promoting protein, is well illustrated to three hotspot p53 mutations at R248, R175, and R273 with distinct molecular mechanisms. Yet, less is known about another hotspot p53 mutant, R249S (p53-R249S). p53-R249S is the sole hotspot mutation in hepatocellular carcinoma (HCC) that is highly associated with chronic hepatitis B virus (HBV) infection and dietary exposure to aflatoxin B1 (AFB1). Its GOF is suggested by the facts that this mutant is associated with earlier onset of HCC and poorer prognosis of cancer patients and that its overexpression drives HCC proliferation and tumorigenesis. By contrast, simply knocking in this mutant in normal mice did not show apparent GOF activity. Hence, the GOF activity for p53-R249S and its underlying mechanisms have been elusive until recent findings offered some new insights. This review will discuss these findings as well as their clinical significance and implications for the development of a strategy to target multiple molecules as a therapy for p53-R249S-harboring HCC.
AuthorsHuai Wang, Peng Liao, Shelya X Zeng, Hua Lu
JournalJournal of molecular cell biology (J Mol Cell Biol) Vol. 11 Issue 4 Pg. 277-283 (04 01 2019) ISSN: 1759-4685 [Electronic] United States
PMID30608603 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Copyright© The Author(s) (2019). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, IBCB, SIBS, CAS.
Chemical References
  • NIMA-Interacting Peptidylprolyl Isomerase
  • Proto-Oncogene Proteins c-myc
  • Tumor Suppressor Protein p53
  • Cyclin D1
Topics
  • Animals
  • Carcinogenesis
  • Carcinoma, Hepatocellular (metabolism, pathology)
  • Cyclin D1 (metabolism)
  • Gain of Function Mutation
  • Humans
  • Liver Neoplasms (metabolism, pathology)
  • NIMA-Interacting Peptidylprolyl Isomerase (metabolism)
  • Proto-Oncogene Proteins c-myc (metabolism)
  • Tumor Suppressor Protein p53 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: